Annual long term liabilities:
$465.25M-$141.63M(-23.34%)Summary
- As of today (September 17, 2025), PCRX annual total long term liabilities is $465.25 million, with the most recent change of -$141.63 million (-23.34%) on December 31, 2024.
- During the last 3 years, PCRX annual long term liabilities has fallen by -$358.58 million (-43.53%).
- PCRX annual long term liabilities is now -43.53% below its all-time high of $823.83 million, reached on December 31, 2021.
Performance
PCRX Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$46.95M-$1.48M(-3.06%)Summary
- As of today (September 17, 2025), PCRX quarterly total long term liabilities is $46.95 million, with the most recent change of -$1.48 million (-3.06%) on June 30, 2025.
- Over the past year, PCRX quarterly long term liabilities has dropped by -$627.91 million (-93.04%).
- PCRX quarterly long term liabilities is now -94.65% below its all-time high of $876.83 million, reached on March 31, 2022.
Performance
PCRX quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
PCRX Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -23.3% | -93.0% |
| 3 y3 years | -43.5% | -94.4% |
| 5 y5 years | +26.3% | -88.5% |
PCRX Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -43.5% | at low | -94.4% | at low |
| 5 y | 5-year | -43.5% | +26.3% | -94.7% | at low |
| alltime | all time | -43.5% | +6919.4% | -94.7% | +644.6% |
PCRX Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $46.95M(-3.1%) |
| Mar 2025 | - | $48.43M(-89.6%) |
| Dec 2024 | $465.25M(-23.3%) | $465.25M(-0.1%) |
| Sep 2024 | - | $465.71M(-31.0%) |
| Jun 2024 | - | $674.85M(+12.9%) |
| Mar 2024 | - | $597.72M(-1.5%) |
| Dec 2023 | $606.87M(-20.0%) | $606.87M(-0.4%) |
| Sep 2023 | - | $609.25M(-2.6%) |
| Jun 2023 | - | $625.49M(-4.7%) |
| Mar 2023 | - | $656.68M(-13.4%) |
| Dec 2022 | $758.42M(-7.9%) | $758.42M(-8.9%) |
| Sep 2022 | - | $832.72M(-1.4%) |
| Jun 2022 | - | $844.17M(-3.7%) |
| Mar 2022 | - | $876.83M(+6.4%) |
| Dec 2021 | $823.83M(+105.2%) | $823.83M(+100.1%) |
| Sep 2021 | - | $411.61M(+0.4%) |
| Jun 2021 | - | $409.97M(+1.3%) |
| Mar 2021 | - | $404.65M(+0.8%) |
| Dec 2020 | $401.50M(+9.0%) | $401.50M(-26.9%) |
| Sep 2020 | - | $549.31M(+34.8%) |
| Jun 2020 | - | $407.38M(+11.0%) |
| Mar 2020 | - | $367.03M(-0.4%) |
| Dec 2019 | $368.45M(+19.8%) | $368.45M(+0.8%) |
| Sep 2019 | - | $365.49M(+0.6%) |
| Jun 2019 | - | $363.19M(+9.2%) |
| Mar 2019 | - | $332.65M(+8.2%) |
| Dec 2018 | $307.47M(+5.1%) | $307.47M(+1.4%) |
| Sep 2018 | - | $303.26M(+1.4%) |
| Jun 2018 | - | $299.14M(+1.4%) |
| Mar 2018 | - | $295.15M(+0.8%) |
| Dec 2017 | $292.67M | $292.67M(+1.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2017 | - | $288.95M(+0.6%) |
| Jun 2017 | - | $287.19M(+1523.5%) |
| Mar 2017 | - | $17.69M(-86.1%) |
| Dec 2016 | $127.65M(+552.8%) | $127.65M(+532.8%) |
| Sep 2016 | - | $20.17M(-7.9%) |
| Jun 2016 | - | $21.91M(+15.9%) |
| Mar 2016 | - | $18.90M(-3.4%) |
| Dec 2015 | $19.55M(+31.1%) | $19.55M(+34.3%) |
| Sep 2015 | - | $14.56M(+2.3%) |
| Jun 2015 | - | $14.24M(-2.2%) |
| Mar 2015 | - | $14.56M(-2.4%) |
| Dec 2014 | $14.92M(+125.1%) | $14.92M(-1.2%) |
| Sep 2014 | - | $15.10M(+3.4%) |
| Jun 2014 | - | $14.61M(+128.4%) |
| Mar 2014 | - | $6.39M(-3.5%) |
| Dec 2013 | $6.63M(-79.3%) | $6.63M(+5.1%) |
| Sep 2013 | - | $6.30M(-93.9%) |
| Jun 2013 | - | $103.45M(+0.7%) |
| Mar 2013 | - | $102.75M(+220.7%) |
| Dec 2012 | $32.04M(-3.8%) | $32.04M(+375.3%) |
| Sep 2012 | - | $6.74M(-6.0%) |
| Jun 2012 | - | $7.17M(-43.9%) |
| Mar 2012 | - | $12.79M(-61.6%) |
| Dec 2011 | $33.31M(-66.2%) | $33.31M(-27.4%) |
| Sep 2011 | - | $45.91M(-1.7%) |
| Jun 2011 | - | $46.68M(-0.8%) |
| Mar 2011 | - | $47.06M(-52.3%) |
| Dec 2010 | $98.62M(+87.9%) | $98.62M(+20.3%) |
| Sep 2010 | - | $81.99M(+16.6%) |
| Jun 2010 | - | $70.33M(+34.0%) |
| Dec 2009 | $52.49M(+101.6%) | $52.49M |
| Dec 2008 | $26.04M | - |
FAQ
- What is Pacira BioSciences, Inc. annual total long term liabilities?
- What is the all time high annual long term liabilities for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. annual long term liabilities year-on-year change?
- What is Pacira BioSciences, Inc. quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. quarterly long term liabilities year-on-year change?
What is Pacira BioSciences, Inc. annual total long term liabilities?
The current annual long term liabilities of PCRX is $465.25M
What is the all time high annual long term liabilities for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high annual total long term liabilities is $823.83M
What is Pacira BioSciences, Inc. annual long term liabilities year-on-year change?
Over the past year, PCRX annual total long term liabilities has changed by -$141.63M (-23.34%)
What is Pacira BioSciences, Inc. quarterly total long term liabilities?
The current quarterly long term liabilities of PCRX is $46.95M
What is the all time high quarterly long term liabilities for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high quarterly total long term liabilities is $876.83M
What is Pacira BioSciences, Inc. quarterly long term liabilities year-on-year change?
Over the past year, PCRX quarterly total long term liabilities has changed by -$627.91M (-93.04%)